{"gene":"PF3D7_1408100","run_date":"2026-09-08T14:19:07","timeline":{"discoveries":[{"year":2002,"finding":"PMIII (histo-aspartic protease, PF3D7_1408100) localizes to the food vacuole of P. falciparum and is an active hydrolase despite having a histidine substituted for one of the two catalytic aspartic acid residues conserved in canonical aspartic proteases.","method":"Genome-wide expression analysis, food vacuole localization, enzymatic activity assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization and activity assay in a single study; histidine-for-aspartate substitution at active site is a structurally notable finding confirmed by activity data, but full mechanistic characterization is limited to abstract-level description","pmids":["11782538"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2004,"finding":"Individual targeted gene disruption of PMIII (histo-aspartic protease) by double-crossover homologous recombination yielded viable P. falciparum clones lacking the protein, which showed normal morphology but slower growth in amino acid-limited medium, indicating partial functional redundancy among food vacuole plasmepsins.","method":"Targeted gene disruption (double-crossover homologous recombination), growth assays in rich and amino acid-limited media","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic knockout with defined cellular phenotype in a single lab; growth phenotype measured under two conditions but mechanistic pathway placement is limited","pmids":["15513918"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"}]},{"year":2006,"finding":"Pepstatin A blockade of plasmepsins (including PMIII) in falcipain-2/plasmepsin I/IV triple-knockout parasites was highly potent, demonstrating overlapping function between PMIII and other food vacuole proteases in hemoglobin degradation; hemoglobin-degrading plasmepsins including PMIII are collectively not promising single drug targets due to functional redundancy.","method":"Pharmacological inhibition (pepstatin A) of plasmepsins in knockout parasite lines; growth assays in amino acid-limited medium","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological epistasis in a single lab; PMIII contribution inferred from combinatorial knockouts rather than PMIII-specific manipulation","pmids":["16731623"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"finding":"PMIII (histo-aspartic protease) was identified as a component of an ~200-kDa protein complex in the food vacuole required for hemoglobin degradation and hemozoin formation, co-purifying with falcipain 2/2', plasmepsin II, plasmepsin IV, and heme detoxification protein.","method":"Co-immunoprecipitation followed by mass spectrometry, gel filtration co-elution, glycerol gradient cosedimentation, in vitro protein interaction analyses","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal biochemical methods (Co-IP/MS, gel filtration, glycerol gradient) in a single study; PMIII membership in the complex is established but its individual catalytic contribution within the complex is not dissected","pmids":["23471987"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"finding":"Overexpression of PMIII alone in the 3D7 background failed to alter P. falciparum sensitivity to piperaquine, artesunate, or chloroquine in standard dose-response or piperaquine survival assays, indicating that PMIII copy number increase alone is not sufficient to confer piperaquine resistance.","method":"Transgenic overexpression of PMIII in P. falciparum 3D7; dose-response assays; piperaquine survival assay","journal":"International journal for parasitology. Drugs and drug resistance","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional overexpression experiment with defined drug-sensitivity readout; negative result is informative but limited to a single lab and two drug assay formats","pmids":["30580023"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"}]},{"year":2025,"finding":"CRISPR-Cas9 single and double knockout of PMIII in Cambodian P. falciparum parasites increased sensitivity to piperaquine; PMIII deletion slowed hemoglobin digestion. However, protease inhibitors had minimal impact on PPQ susceptibility, parasites with higher plasmepsin copy numbers did not show significantly increased hemoglobin digestion or different free heme production after PPQ treatment, and amino acid-limited culture had little effect on high-dose PPQ sensitivity—pointing instead toward digestive vacuole pH homeostasis as a contributing mechanism.","method":"CRISPR-Cas9 gene knockout (single and double KO), piperaquine sensitivity assays, hemoglobin digestion assays, protease inhibitor treatment, amino acid-limited culture, digestive vacuole pH modulation","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic manipulations (KO and amplification) across isogenic lines with multiple orthogonal functional readouts in a single rigorous study","pmids":["40720544"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"PMIII (PF3D7_1408100, histo-aspartic protease) is an active aspartic-like protease with a histidine substituting one catalytic aspartate, localizes to the P. falciparum food vacuole as part of an ~200-kDa multi-protein complex with other hemoglobinases, participates redundantly in hemoglobin degradation, and its gene amplification (together with plasmepsin II) modulates parasite piperaquine sensitivity likely through effects on digestive vacuole pH homeostasis rather than through increased proteolytic activity per se."},"narrative":{"mechanistic_narrative":"PMIII (PF3D7_1408100), a food vacuole histo-aspartic protease, participates in hemoglobin degradation as one of several redundant proteases in the P. falciparum digestive vacuole [PMID:11782538, PMID:16731623]. Despite substitution of a histidine for one of the two catalytic aspartate residues conserved in canonical aspartic proteases, PMIII is an active hydrolase and localizes to the food vacuole [PMID:11782538]. It functions within an ~200-kDa multi-protein complex that co-purifies with falcipain 2/2', plasmepsin II, plasmepsin IV, and heme detoxification protein, and is required for hemoglobin degradation and hemozoin formation [PMID:23471987]. Individual gene disruption is tolerated, yielding viable parasites with normal morphology but slowed growth under amino acid limitation, reflecting functional redundancy among the food vacuole plasmepsins [PMID:15513918, PMID:16731623]. PMIII copy number modulates piperaquine sensitivity: CRISPR-Cas9 knockout increases piperaquine sensitivity and slows hemoglobin digestion, yet protease inhibition, plasmepsin amplification, and amino acid limitation do not track with piperaquine susceptibility, implicating digestive vacuole pH homeostasis rather than proteolytic output per se [PMID:40720544]; consistently, PMIII overexpression alone does not alter piperaquine, artesunate, or chloroquine sensitivity [PMID:30580023].","teleology":[{"year":2002,"claim":"Establishing that PMIII is a food-vacuole enzyme answered whether this histidine-substituted family member is catalytically active at all, showing it functions as a hydrolase despite lacking a canonical second catalytic aspartate.","evidence":"Genome-wide expression, food vacuole localization, and enzymatic activity assay in P. falciparum","pmids":["11782538"],"confidence":"Medium","gaps":["Physiological substrate spectrum not defined beyond hemoglobin context","Catalytic mechanism of the His-for-Asp active site not structurally resolved","Individual contribution to hemoglobin degradation not measured"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2004,"claim":"Targeted disruption tested whether PMIII is individually essential, revealing dispensability with only a conditional growth defect and thereby exposing functional redundancy among food-vacuole plasmepsins.","evidence":"Double-crossover homologous recombination knockout and growth assays in rich versus amino acid-limited media in P. falciparum 3D7","pmids":["15513918"],"confidence":"Medium","gaps":["Redundant partners not identified in this study","Mechanistic basis of the amino-acid-limited growth defect not dissected"],"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"}]},{"year":2006,"claim":"Combining plasmepsin inhibition with protease knockouts addressed whether PMIII is a viable single drug target, confirming overlapping proteolytic function makes the hemoglobin-degrading plasmepsins collectively poor single targets.","evidence":"Pepstatin A inhibition in falcipain-2/plasmepsin I/IV knockout lines with growth assays in amino acid-limited medium in P. falciparum","pmids":["16731623"],"confidence":"Medium","gaps":["PMIII-specific contribution inferred from combinatorial rather than PMIII-directed manipulation","Relative catalytic weight of PMIII versus other proteases unquantified"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"claim":"Biochemical purification answered how the food-vacuole hemoglobinases are organized, placing PMIII in an ~200-kDa complex with falcipain 2/2', plasmepsins II and IV, and heme detoxification protein required for hemoglobin degradation and hemozoin formation.","evidence":"Co-IP/MS, gel filtration co-elution, glycerol gradient cosedimentation, and in vitro interaction analyses in P. falciparum","pmids":["23471987"],"confidence":"Medium","gaps":["Individual catalytic contribution of PMIII within the complex not dissected","Stoichiometry and architecture of the complex not resolved","Whether PMIII is required for complex assembly unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"claim":"Overexpression tested whether increased PMIII copy number alone drives antimalarial resistance, showing it is insufficient to alter piperaquine, artesunate, or chloroquine sensitivity.","evidence":"Transgenic PMIII overexpression in P. falciparum 3D7 with dose-response and piperaquine survival assays","pmids":["30580023"],"confidence":"Medium","gaps":["Effect limited to two assay formats and a single genetic background","Does not test co-amplification with plasmepsin II"],"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"}]},{"year":2025,"claim":"Reciprocal CRISPR-Cas9 knockout and amplification separated proteolytic output from drug resistance, showing PMIII loss increases piperaquine sensitivity and slows hemoglobin digestion while implicating digestive vacuole pH homeostasis rather than increased proteolysis as the resistance mechanism.","evidence":"Single/double CRISPR-Cas9 knockouts, piperaquine sensitivity and hemoglobin digestion assays, protease inhibitor and amino-acid-limited culture, and digestive vacuole pH modulation in Cambodian P. falciparum","pmids":["40720544"],"confidence":"High","gaps":["Direct causal link between PMIII and vacuolar pH not mechanistically defined","How PMIII copy number affects pH homeostasis unresolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"The molecular basis by which PMIII activity or copy number influences digestive vacuole pH homeostasis, and how this couples to piperaquine sensitivity, remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No mechanistic model linking PMIII to vacuolar pH regulation","Structure of the His-for-Asp catalytic site and its substrate preference undefined","PMIII's specific role within the ~200-kDa complex not isolated"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["~200-kDa food vacuole hemoglobin-degradation complex (with falcipain 2/2', plasmepsin II, plasmepsin IV, and heme detoxification protein) [#3]"],"partners":["FALCIPAIN 2/2' [#3]","PLASMEPSIN II [#3]","PLASMEPSIN IV [#3]","HEME DETOXIFICATION PROTEIN [#3]"],"other_free_text":["Active hydrolase despite a histidine substituting for one of the two conserved catalytic aspartate residues [#0]","Individually dispensable; knockout parasites are viable with a growth defect under amino acid limitation, reflecting redundancy among food vacuole plasmepsins [#1, #2]","Knockout increases piperaquine sensitivity and slows hemoglobin digestion, but resistance tracks with digestive vacuole pH homeostasis rather than proteolytic output [#5]","Overexpression alone does not change piperaquine, artesunate, or chloroquine sensitivity [#4]"]}},"prefetch_data":{},"corpus_meta":[{"pmid":"11782538","id":"PMC_11782538","title":"Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11782538","citation_count":346,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"27818095","id":"PMC_27818095","title":"Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.","date":"2016","source":"The Lancet. Infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/27818095","citation_count":306,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16731623","id":"PMC_16731623","title":"Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16731623","citation_count":278,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["III"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11872398","id":"PMC_11872398","title":"Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.","date":"2001","source":"Trends in parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/11872398","citation_count":254,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15513918","id":"PMC_15513918","title":"The role of Plasmodium falciparum food vacuole plasmepsins.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15513918","citation_count":157,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23471987","id":"PMC_23471987","title":"Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23471987","citation_count":131,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29720620","id":"PMC_29720620","title":"Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29720620","citation_count":96,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin III","III"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32366462","id":"PMC_32366462","title":"Malaria parasite plasmepsins: More than just plain old degradative pepsins.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32366462","citation_count":64,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin III","III"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30580023","id":"PMC_30580023","title":"Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine.","date":"2018","source":"International journal for parasitology. Drugs and drug resistance","url":"https://pubmed.ncbi.nlm.nih.gov/30580023","citation_count":37,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin III","III"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20180801","id":"PMC_20180801","title":"New insights into protein export in malaria parasites.","date":"2010","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/20180801","citation_count":34,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["III"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"40720544","id":"PMC_40720544","title":"The plasmepsin-piperaquine paradox persists in Plasmodium falciparum.","date":"2025","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/40720544","citation_count":3,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin III","III"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8029,"output_tokens":1849,"usd":0.025911,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":7019,"output_tokens":3083,"usd":0.056085,"stage2_stop_reason":"end_turn"},"total_usd":0.081996,"stage1_batch_id":"msgbatch_011BPjN2BL33F8cJXD1r7V7T","stage2_batch_id":"msgbatch_01Qwg6vP7qxkpL6Gsc7tajsb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"PMIII (histo-aspartic protease, PF3D7_1408100) localizes to the food vacuole of P. falciparum and is an active hydrolase despite having a histidine substituted for one of the two catalytic aspartic acid residues conserved in canonical aspartic proteases.\",\n      \"method\": \"Genome-wide expression analysis, food vacuole localization, enzymatic activity assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization and activity assay in a single study; histidine-for-aspartate substitution at active site is a structurally notable finding confirmed by activity data, but full mechanistic characterization is limited to abstract-level description\",\n      \"pmids\": [\"11782538\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Individual targeted gene disruption of PMIII (histo-aspartic protease) by double-crossover homologous recombination yielded viable P. falciparum clones lacking the protein, which showed normal morphology but slower growth in amino acid-limited medium, indicating partial functional redundancy among food vacuole plasmepsins.\",\n      \"method\": \"Targeted gene disruption (double-crossover homologous recombination), growth assays in rich and amino acid-limited media\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic knockout with defined cellular phenotype in a single lab; growth phenotype measured under two conditions but mechanistic pathway placement is limited\",\n      \"pmids\": [\"15513918\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Pepstatin A blockade of plasmepsins (including PMIII) in falcipain-2/plasmepsin I/IV triple-knockout parasites was highly potent, demonstrating overlapping function between PMIII and other food vacuole proteases in hemoglobin degradation; hemoglobin-degrading plasmepsins including PMIII are collectively not promising single drug targets due to functional redundancy.\",\n      \"method\": \"Pharmacological inhibition (pepstatin A) of plasmepsins in knockout parasite lines; growth assays in amino acid-limited medium\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological epistasis in a single lab; PMIII contribution inferred from combinatorial knockouts rather than PMIII-specific manipulation\",\n      \"pmids\": [\"16731623\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PMIII (histo-aspartic protease) was identified as a component of an ~200-kDa protein complex in the food vacuole required for hemoglobin degradation and hemozoin formation, co-purifying with falcipain 2/2', plasmepsin II, plasmepsin IV, and heme detoxification protein.\",\n      \"method\": \"Co-immunoprecipitation followed by mass spectrometry, gel filtration co-elution, glycerol gradient cosedimentation, in vitro protein interaction analyses\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal biochemical methods (Co-IP/MS, gel filtration, glycerol gradient) in a single study; PMIII membership in the complex is established but its individual catalytic contribution within the complex is not dissected\",\n      \"pmids\": [\"23471987\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Overexpression of PMIII alone in the 3D7 background failed to alter P. falciparum sensitivity to piperaquine, artesunate, or chloroquine in standard dose-response or piperaquine survival assays, indicating that PMIII copy number increase alone is not sufficient to confer piperaquine resistance.\",\n      \"method\": \"Transgenic overexpression of PMIII in P. falciparum 3D7; dose-response assays; piperaquine survival assay\",\n      \"journal\": \"International journal for parasitology. Drugs and drug resistance\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional overexpression experiment with defined drug-sensitivity readout; negative result is informative but limited to a single lab and two drug assay formats\",\n      \"pmids\": [\"30580023\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"}]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CRISPR-Cas9 single and double knockout of PMIII in Cambodian P. falciparum parasites increased sensitivity to piperaquine; PMIII deletion slowed hemoglobin digestion. However, protease inhibitors had minimal impact on PPQ susceptibility, parasites with higher plasmepsin copy numbers did not show significantly increased hemoglobin digestion or different free heme production after PPQ treatment, and amino acid-limited culture had little effect on high-dose PPQ sensitivity—pointing instead toward digestive vacuole pH homeostasis as a contributing mechanism.\",\n      \"method\": \"CRISPR-Cas9 gene knockout (single and double KO), piperaquine sensitivity assays, hemoglobin digestion assays, protease inhibitor treatment, amino acid-limited culture, digestive vacuole pH modulation\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic manipulations (KO and amplification) across isogenic lines with multiple orthogonal functional readouts in a single rigorous study\",\n      \"pmids\": [\"40720544\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"PMIII (PF3D7_1408100, histo-aspartic protease) is an active aspartic-like protease with a histidine substituting one catalytic aspartate, localizes to the P. falciparum food vacuole as part of an ~200-kDa multi-protein complex with other hemoglobinases, participates redundantly in hemoglobin degradation, and its gene amplification (together with plasmepsin II) modulates parasite piperaquine sensitivity likely through effects on digestive vacuole pH homeostasis rather than through increased proteolytic activity per se.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PMIII (PF3D7_1408100), a food vacuole histo-aspartic protease, participates in hemoglobin degradation as one of several redundant proteases in the P. falciparum digestive vacuole [#0, #2]. Despite substitution of a histidine for one of the two catalytic aspartate residues conserved in canonical aspartic proteases, PMIII is an active hydrolase and localizes to the food vacuole [#0]. It functions within an ~200-kDa multi-protein complex that co-purifies with falcipain 2/2', plasmepsin II, plasmepsin IV, and heme detoxification protein, and is required for hemoglobin degradation and hemozoin formation [#3]. Individual gene disruption is tolerated, yielding viable parasites with normal morphology but slowed growth under amino acid limitation, reflecting functional redundancy among the food vacuole plasmepsins [#1, #2]. PMIII copy number modulates piperaquine sensitivity: CRISPR-Cas9 knockout increases piperaquine sensitivity and slows hemoglobin digestion, yet protease inhibition, plasmepsin amplification, and amino acid limitation do not track with piperaquine susceptibility, implicating digestive vacuole pH homeostasis rather than proteolytic output per se [#5]; consistently, PMIII overexpression alone does not alter piperaquine, artesunate, or chloroquine sensitivity [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing that PMIII is a food-vacuole enzyme answered whether this histidine-substituted family member is catalytically active at all, showing it functions as a hydrolase despite lacking a canonical second catalytic aspartate.\",\n      \"evidence\": \"Genome-wide expression, food vacuole localization, and enzymatic activity assay in P. falciparum\",\n      \"pmids\": [\"11782538\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Physiological substrate spectrum not defined beyond hemoglobin context\",\n        \"Catalytic mechanism of the His-for-Asp active site not structurally resolved\",\n        \"Individual contribution to hemoglobin degradation not measured\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Targeted disruption tested whether PMIII is individually essential, revealing dispensability with only a conditional growth defect and thereby exposing functional redundancy among food-vacuole plasmepsins.\",\n      \"evidence\": \"Double-crossover homologous recombination knockout and growth assays in rich versus amino acid-limited media in P. falciparum 3D7\",\n      \"pmids\": [\"15513918\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Redundant partners not identified in this study\",\n        \"Mechanistic basis of the amino-acid-limited growth defect not dissected\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"}]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Combining plasmepsin inhibition with protease knockouts addressed whether PMIII is a viable single drug target, confirming overlapping proteolytic function makes the hemoglobin-degrading plasmepsins collectively poor single targets.\",\n      \"evidence\": \"Pepstatin A inhibition in falcipain-2/plasmepsin I/IV knockout lines with growth assays in amino acid-limited medium in P. falciparum\",\n      \"pmids\": [\"16731623\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"PMIII-specific contribution inferred from combinatorial rather than PMIII-directed manipulation\",\n        \"Relative catalytic weight of PMIII versus other proteases unquantified\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Biochemical purification answered how the food-vacuole hemoglobinases are organized, placing PMIII in an ~200-kDa complex with falcipain 2/2', plasmepsins II and IV, and heme detoxification protein required for hemoglobin degradation and hemozoin formation.\",\n      \"evidence\": \"Co-IP/MS, gel filtration co-elution, glycerol gradient cosedimentation, and in vitro interaction analyses in P. falciparum\",\n      \"pmids\": [\"23471987\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Individual catalytic contribution of PMIII within the complex not dissected\",\n        \"Stoichiometry and architecture of the complex not resolved\",\n        \"Whether PMIII is required for complex assembly unknown\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Overexpression tested whether increased PMIII copy number alone drives antimalarial resistance, showing it is insufficient to alter piperaquine, artesunate, or chloroquine sensitivity.\",\n      \"evidence\": \"Transgenic PMIII overexpression in P. falciparum 3D7 with dose-response and piperaquine survival assays\",\n      \"pmids\": [\"30580023\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Effect limited to two assay formats and a single genetic background\",\n        \"Does not test co-amplification with plasmepsin II\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"}]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Reciprocal CRISPR-Cas9 knockout and amplification separated proteolytic output from drug resistance, showing PMIII loss increases piperaquine sensitivity and slows hemoglobin digestion while implicating digestive vacuole pH homeostasis rather than increased proteolysis as the resistance mechanism.\",\n      \"evidence\": \"Single/double CRISPR-Cas9 knockouts, piperaquine sensitivity and hemoglobin digestion assays, protease inhibitor and amino-acid-limited culture, and digestive vacuole pH modulation in Cambodian P. falciparum\",\n      \"pmids\": [\"40720544\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct causal link between PMIII and vacuolar pH not mechanistically defined\",\n        \"How PMIII copy number affects pH homeostasis unresolved\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular basis by which PMIII activity or copy number influences digestive vacuole pH homeostasis, and how this couples to piperaquine sensitivity, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No mechanistic model linking PMIII to vacuolar pH regulation\",\n        \"Structure of the His-for-Asp catalytic site and its substrate preference undefined\",\n        \"PMIII's specific role within the ~200-kDa complex not isolated\"\n      ],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004190\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020020\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0044277\", \"supporting_discovery_ids\": [1, 2, 3, 5]}\n    ],\n    \"complexes\": [\n      \"~200-kDa food vacuole hemoglobin-degradation complex (with falcipain 2/2', plasmepsin II, plasmepsin IV, and heme detoxification protein) [#3]\"\n    ],\n    \"partners\": [\n      \"falcipain 2/2' [#3]\",\n      \"plasmepsin II [#3]\",\n      \"plasmepsin IV [#3]\",\n      \"heme detoxification protein [#3]\"\n    ],\n    \"other_free_text\": [\n      \"Active hydrolase despite a histidine substituting for one of the two conserved catalytic aspartate residues [#0]\",\n      \"Individually dispensable; knockout parasites are viable with a growth defect under amino acid limitation, reflecting redundancy among food vacuole plasmepsins [#1, #2]\",\n      \"Knockout increases piperaquine sensitivity and slows hemoglobin digestion, but resistance tracks with digestive vacuole pH homeostasis rather than proteolytic output [#5]\",\n      \"Overexpression alone does not change piperaquine, artesunate, or chloroquine sensitivity [#4]\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_1408100","name":null,"product":"plasmepsin III","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"PMIII","evaluation":null}